John Reed, Director of Cancer Therapy at Siemens Healthineers, shared on LinkedIn:
“Did you know that advanced MR imaging can help radiation oncology teams stay one step ahead of a moving target in liver cancer treatment?
Hepatocellular carcinoma (HCC) presents a unique challenge for radiation oncology: treating a moving target while preserving healthy liver function. As liver SBRT continues to evolve, advanced imaging may provide additional information on tumor location and motion to inform treatment strategy discussions.
Join Wensha Yang, University of California, San Francisco (UCSF) and Sushil Beriwal, Varian Medical Affairs at Siemens Healthineers, as they share emerging clinical perspectives and practical insights on liver cancer radiotherapy.
During this webinar you will learn about
- The evolving role of SBRT in HCC management
- Key considerations for advanced imaging, motion management, and patient selection
- How MRI-based motion assessment can support individualized liver radiotherapy planning and liver preservation
When? October 14, 11:00 am – 12:00 am EDT
Where? See.”
You may also be interested in: Nivolumab With deb-TACE in Liver-Limited Hepatocellular Carcinoma
